Interferons: mechanisms of action and clinical applications.
about
Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoformsNovel type I interferon IL-28A suppresses hepatitis C viral RNA replication.Innate Immunity and Immune Evasion by Enterovirus 71Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signalingLoss of Ifnar1 in Pancreatic Acinar Cells Ameliorates the Disease Course of Acute PancreatitisNovel Alpha Interferon (IFN- ) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN- 2b Therapy in a Subgenomic Replicon SystemInterferon Alpha Treatment and Thyroid DysfunctionOncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial CellsGene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice.Interferon induced thyroiditis.Hepatitis C and interferon induced thyroiditis.Ubiquitination-dependent regulation of signaling receptors in cancer.Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitroAdenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effectsBID is a critical factor controlling cell viability regulated by IFN-α.Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.Cutaneous T-cell lymphoma: a paradigm for biological therapies.Synthetic lethality of PARP inhibition in BRCA-network disrupted tumor cells is associated with interferon pathway activation and enhanced by interferon-γ.Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responsesGene Expression Profiling Identifies Interferon Signalling Molecules and IGFBP3 in Human Degenerative Annulus FibrosusPlasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.Role of the Akt pathway in mRNA translation of interferon-stimulated genes.The genetics and biology of Irf5-mediated signaling in lupus.An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells.Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursorsInteraction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.Opportunistic autoimmune disorders: from immunotherapy to immune dysregulationExpression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma.Role of Schlafen 2 (SLFN2) in the generation of interferon alpha-induced growth inhibitory responsesPrevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapyIRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.Long-term pegylated interferon-alpha and its potential in the treatment of melanomaChemokines in tumor-associated angiogenesis.Interferons as potential adjuvants in prophylactic vaccines.Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment.Regulation of interferon-dependent mRNA translation of target genesInfluence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells.
P2860
Q24814274-CED159B4-ACE6-477A-BBCE-C408EDAF817EQ24815995-2CC8E33D-4A3A-4CBA-9352-585522980289Q26773329-97BF9931-BABD-4C79-8604-A8FAA560FB94Q27310374-E40E7F82-E517-479A-AEFF-E4662C4948A6Q27339244-18349EDC-0094-41EE-9BFD-849DB3636818Q27477758-94E82209-25BF-40C6-97A6-C8C763DB157DQ27483686-8FBDC52A-DD53-4F60-B7BE-74DF6421BA46Q27488206-BCA9E160-BDCA-4021-AF0E-BA16E3BDD047Q33387408-021AAA9D-A93E-482A-9522-1DAFB2157E5BQ33636049-8DA68D96-1590-4488-8800-0CA44BD47909Q33716540-7E383FB4-E269-4B28-958D-E9EB01A883B2Q34365210-9FB9365B-25DE-44BC-B497-13818F2872DBQ34401177-A2F678F8-3F8D-4C8F-A1F3-EAC0137EF830Q35578111-3602D7C5-1C58-440C-B150-3CAB722B0CE8Q35620657-36F7F1FA-C979-4045-A90A-3F6E8C347BBFQ35621716-8EA6F815-0816-42EB-930A-ABBA64FAB377Q35763478-BC50B9AC-B83F-4600-978A-4C2961ADA84FQ35821012-54994048-FB0A-47A9-927C-C0A69FA838DCQ35879098-4345A4A1-1CC5-4158-93D7-CBDC8EB0A62DQ35974114-BC7236DC-9E45-43F2-BA87-39D5DFE230F9Q36188811-9EF8DC67-F959-4C41-83B4-CB7025EB54FBQ36200438-67ACC13C-1B9B-47DF-B75A-25AF4F86E64FQ36534292-02F67D80-1A61-4CCB-B68F-35E85C2E0F7BQ37030639-53702642-3265-42DE-8FD3-A78FB085717DQ37046825-C32B609F-A543-4F17-941B-C6C5BD587D72Q37099708-D0BDC8EA-D30D-4370-989E-E1743ABE807AQ37260388-308AB12D-A20E-401F-BEEA-833E6E815A0CQ37274049-F266A25E-EDFA-4000-91AD-13A2D560FF3BQ37311350-6295FA83-29C2-4511-92E2-A1B143F54115Q37327294-91B8866F-DC97-4934-BE61-FD3FEC2E883DQ37375719-0B1E38F6-206E-4F73-A69C-6AC5F216ABDCQ37412136-3BA571FD-1304-4BBF-A910-5A436E009D54Q37485142-5D5066E1-4E47-4494-A5D8-DFBAE3A9452FQ37586916-C4F1873D-FD8F-4698-A37B-F3EE10E59609Q37608615-F72908FA-70F5-4D13-98EF-931C779E0551Q37788270-987CC349-812D-4385-A305-246BA3E8968EQ38093766-74D4F459-C6AD-4098-92CE-4855BB2E3185Q38121422-6F0C45C5-88B2-49FE-A006-6B45EA763219Q38190098-715EF98D-3129-4574-B2D2-8E85D6DA27A9Q38281748-5B4480B3-BDE8-4DB7-AC24-E8CFBC981038
P2860
Interferons: mechanisms of action and clinical applications.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Interferons: mechanisms of action and clinical applications.
@ast
Interferons: mechanisms of action and clinical applications.
@en
type
label
Interferons: mechanisms of action and clinical applications.
@ast
Interferons: mechanisms of action and clinical applications.
@en
prefLabel
Interferons: mechanisms of action and clinical applications.
@ast
Interferons: mechanisms of action and clinical applications.
@en
P1476
Interferons: mechanisms of action and clinical applications.
@en
P2093
Leonidas C Platanias
Simrit Parmar
P304
P356
10.1097/00001622-200311000-00005
P577
2003-11-01T00:00:00Z